Star Equity Holdings, Inc. (STRR) 10-Year Financial Performance & Capital Metrics

STRR • • Industrial / General

HealthcareDiagnostics & ResearchClinical Laboratory ServicesSpecialized Testing Laboratories

AboutStar Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals. The company also develops, sells, and maintains solid-state gamma cameras; and provides camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.Show more

Revenue $53M -66.9%
EBITDA -$5M -268.9%
Net Income -$10M -574.9%
EPS (Diluted) -3.97 -257.7%
Gross Margin 20.72% -58.4%
EBITDA Margin -9.02% -610.6%
Operating Margin -15.77% -1939.8%
Net Margin -19.56% -1535.8%
ROE -23.46% -603.5%
ROIC -24.34% -663.0%
Debt/Equity 0.03 -10.8%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Healthy dividend yield of 5.9%
✓Share count reduced 23.8% through buybacks
✓Trading at only 0.9x book value
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Sales declining 6.1% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.41%

5Y-6.06%

3Y-20.59%

TTM56.35%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-109.32%

EPS CAGR

10Y-

5Y-

3Y-

TTM48.46%

ROCE

10Y Avg-7.79%

5Y Avg-12.91%

3Y Avg-7.55%

Latest-18.47%

Peer Comparison

Specialized Testing Laboratories

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
RDNTRadNet, Inc.	5.64B	72.99	1951.60	13.18%	-0.65%	-0.97%	0.8%	1.53
IDXXIDEXX Laboratories, Inc.	56.86B	712.12	66.74	6.46%	24.65%	65.81%	1.4%	0.62
CDNACareDx, Inc	1.06B	20.57	22.12	19.07%	16.97%	19.53%	2.98%	0.07
TRIBTrinity Biotech plc	13.23M	0.71	-0.40	8.31%	-73.78%
NEOGNeogen Corporation	2.06B	9.46	-1.88	-3.2%	-68.47%	-28.64%		0.44
STRRStar Equity Holdings, Inc.	38.07M	10.96	-2.76	-66.93%	-5.36%	-8.98%		0.03
BGLCBioNexus Gene Lab Corp.	8.72M	3.69	-4.10	-2.66%	-24.27%	-33.7%		0.03
NEONeoGenomics, Inc.	1.66B	12.83	-4.14	11.65%	-16%	-13.54%		0.67

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	60.83M	125.47M	118.34M	104.18M	72.93M	78.16M	106.56M	112.15M	161.34M	53.36M
Revenue Growth %	0.09%	1.06%	-0.06%	-0.12%	-0.3%	0.07%	0.36%	0.05%	0.44%	-0.67%
Cost of Goods Sold+	42.92M	89.69M	89.94M	85.91M	55.77M	64.18M	91.32M	86.27M	81.07M	42.3M
COGS % of Revenue	0.71%	0.71%	0.76%	0.82%	0.76%	0.82%	0.86%	0.77%	0.5%	0.79%
Gross Profit+	17.91M	35.77M	28.4M	18.27M	17.16M	13.99M	15.24M	25.88M	80.27M	11.05M
Gross Margin %	0.29%	0.29%	0.24%	0.18%	0.24%	0.18%	0.14%	0.23%	0.5%	0.21%
Gross Profit Growth %	0.08%	1%	-0.21%	-0.36%	-0.06%	-0.18%	0.09%	0.7%	2.1%	-0.86%
Operating Expenses+	15.13M	32.69M	26.5M	22.82M	19.07M	21.2M	26.84M	28.98M	78.88M	19.47M
OpEx % of Revenue	0.25%	0.26%	0.22%	0.22%	0.26%	0.27%	0.25%	0.26%	0.49%	0.36%
Selling, General & Admin	14.63M	30.04M	24.84M	20.46M	15.9M	18.64M	22.59M	27.26M	77.42M	16.99M
SG&A % of Revenue	0.24%	0.24%	0.21%	0.2%	0.22%	0.24%	0.21%	0.24%	0.48%	0.32%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	506K	4.51M	3M	2.36M	3.17M	2.56M	4.24M	1.72M	1.47M	2.48M
Operating Income+	2.77M	3.08M	-6.02M	-4.54M	-1.91M	-7.21M	-11.6M	-3.1M	1.38M	-8.41M
Operating Margin %	0.05%	0.02%	-0.05%	-0.04%	-0.03%	-0.09%	-0.11%	-0.03%	0.01%	-0.16%
Operating Income Growth %	0.1%	0.11%	-2.95%	0.24%	0.58%	-2.78%	-0.61%	0.73%	1.45%	-7.08%
EBITDA+	5.21M	12.97M	5.04M	4.16M	6.17M	2.81M	-6.66M	430K	2.85M	-4.81M
EBITDA Margin %	0.09%	0.1%	0.04%	0.04%	0.08%	0.04%	-0.06%	0%	0.02%	-0.09%
EBITDA Growth %	0.17%	1.49%	-0.61%	-0.17%	0.48%	-0.54%	-3.37%	1.06%	5.63%	-2.69%
D&A (Non-Cash Add-back)	2.44M	9.89M	11.06M	8.71M	8.07M	10.02M	4.93M	3.54M	1.47M	3.6M
EBIT	2.54M	5.28M	-6.32M	-4.65M	-2.19M	-3.86M	-7.97M	-3.54M	1.38M	-8.41M
Net Interest Income+	-24K	-1.41M	-730K	-751K	-746K	-1.29M	-905K	-564K	372K	633K
Interest Income	272K	0	0	0	0	0	0	0	372K	633K
Interest Expense	296K	1.41M	730K	751K	746K	1.29M	905K	564K	0	0
Other Income/Expense	-257K	-1.2M	-1.03M	-855K	-1.03M	2.05M	2.72M	-2.34M	1.19M	-1.76M
Pretax Income+	2.52M	1.89M	-7.05M	-5.4M	-2.94M	-5.16M	-8.87M	-5.44M	2.57M	-10.18M
Pretax Margin %	0.04%	0.02%	-0.06%	-0.05%	-0.04%	-0.07%	-0.08%	-0.05%	0.02%	-0.19%
Income Tax+	-19.12M	-12.42M	27.99M	-1.56M	-199K	129K	60K	383K	370K	263K
Effective Tax Rate %	8.6%	7.59%	5.07%	-0.14%	1.57%	1.25%	0.34%	0.96%	0.86%	1.03%
Net Income+	21.64M	14.3M	-35.73M	736K	-4.63M	-6.46M	-2.98M	-5.25M	2.2M	-10.44M
Net Margin %	0.36%	0.11%	-0.3%	0.01%	-0.06%	-0.08%	-0.03%	-0.05%	0.01%	-0.2%
Net Income Growth %	7.74%	-0.34%	-3.5%	1.02%	-7.29%	-0.4%	0.54%	-0.76%	1.42%	-5.75%
Net Income (Continuing)	21.64M	14.3M	-35.04M	-3.84M	-2.74M	-5.29M	-8.93M	-5.83M	2.2M	-10.44M
Discontinued Operations	0	0	0	4.58M	-1.89M	-1.17M	5.95M	575K	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	55.00	35.50	-17.87	2.00	-2.56	-2.29	-0.96	-1.27	-1.11	-3.97
EPS Growth %	7.46%	-0.35%	-1.5%	1.11%	-2.28%	0.11%	0.58%	-0.32%	0.13%	-2.58%
EPS (Basic)	56.50	36.50	-17.87	0.04	-2.56	-2.29	-0.96	-1.27	-1.11	-3.97
Diluted Shares Outstanding	1.97M	2.01M	2M	2.02M	2.04M	3.66M	5.08M	4.13M	4.13M	3.15M
Basic Shares Outstanding	1.92M	1.96M	2M	2.02M	2.04M	3.66M	5.08M	4.13M	4.13M	3.15M
Dividend Payout Ratio	0.18%	0.27%	-	4.51%	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	31.75M	27.08M	25.58M	21.19M	29.55M	48.94M	49.16M	55.51M	45.85M	40.14M
Cash & Short-Term Investments	19.09M	3.12M	1.97M	1.7M	1.77M	3.23M	21.71M	27.12M	22.61M	17.01M
Cash Only	15.87M	2.2M	1.88M	1.54M	1.75M	3.23M	21.71M	27.12M	22.61M	17.01M
Short-Term Investments	3.23M	917K	97K	153K	26K	0	0	0	0	0
Accounts Receivable	7.27M	14.5M	15.89M	12.64M	12.92M	12.97M	25.75M	26.27M	19.71M	20.09M
Days Sales Outstanding	43.65	42.19	49	44.29	64.64	60.59	88.2	85.5	44.59	137.45
Inventory	4.38M	5.99M	5.5M	5.4M	7.03M	9.79M	0	0	0	0
Days Inventory Outstanding	37.26	24.36	22.33	22.95	46	55.66	-	-	-	-
Other Current Assets	997K	3.47M	2.21M	1.45M	7.83M	22.95M	222K	2.12M	3.53M	3.04M
Total Non-Current Assets+	32.37M	79.18M	41.13M	29.4M	61.01M	40.52M	12.08M	12.43M	15.11M	12.44M
Property, Plant & Equipment	6.25M	31.41M	28.36M	21.64M	12.52M	12.7M	848K	1.36M	1.85M	1.27M
Fixed Asset Turnover	9.73x	3.99x	4.17x	4.81x	5.82x	6.16x	125.66x	82.59x	87.12x	42.15x
Goodwill	2.9M	6.24M	2.39M	1.75M	9.98M	9.54M	4.22M	4.88M	5.75M	5.7M
Intangible Assets	3.08M	11.63M	7.83M	5.23M	19.02M	16.9M	5.49M	4.52M	3.63M	2.49M
Long-Term Investments	0	0	0	275K	0	0	0	0	0	0
Other Non-Current Assets	1.56M	2.89M	2.54M	507K	19.49M	1.38M	182K	206K	522K	335K
Total Assets+	64.11M	106.26M	66.7M	50.59M	90.56M	89.46M	61.24M	67.94M	60.96M	52.58M
Asset Turnover	0.95x	1.18x	1.77x	2.06x	0.81x	0.87x	1.74x	1.65x	2.65x	1.01x
Asset Growth %	0.53%	0.66%	-0.37%	-0.24%	0.79%	-0.01%	-0.32%	0.11%	-0.1%	-0.14%
Total Current Liabilities+	8.71M	22.67M	16.97M	13.22M	44.48M	42.99M	19.69M	21.12M	11.21M	11.22M
Accounts Payable	1.37M	6.51M	5.21M	5.21M	6.46M	4.95M	871K	1.68M	868K	1.79M
Days Payables Outstanding	11.64	26.51	21.13	22.12	42.29	28.16	3.48	7.1	3.91	15.44
Short-Term Debt	0	5.36M	0	0	22.25M	20.67M	750K	1.25M	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	533K	170K	96K	129K
Other Current Liabilities	2.45M	3.96M	6.34M	3.86M	8.23M	10.7M	0	75K	0	0
Current Ratio	3.65x	1.19x	1.51x	1.60x	0.66x	1.14x	2.50x	2.63x	4.09x	3.58x
Quick Ratio	3.14x	0.93x	1.18x	1.19x	0.51x	0.91x	2.50x	2.63x	4.09x	3.58x
Cash Conversion Cycle	69.27	40.05	50.19	45.12	68.35	88.09	-	-	-	-
Total Non-Current Liabilities+	1.25M	17.11M	21.93M	11.58M	5.39M	6.54M	2.23M	1.03M	1.19M	933K
Long-Term Debt	0	16.07M	19.5M	9.5M	740K	3.7M	1.25M	0	0	0
Capital Lease Obligations	0	0	0	0	1.21M	1.73M	118K	348K	664K	441K
Deferred Tax Liabilities	0	0	254K	121K	11K	51K	0	0	0	0
Other Non-Current Liabilities	1.25M	1.04M	2.18M	1.96M	3.43M	1.06M	865K	680K	530K	492K
Total Liabilities	9.96M	39.78M	38.9M	24.79M	49.86M	49.53M	21.93M	22.15M	12.4M	12.15M
Total Debt+	724K	22.07M	20.3M	10.29M	25.9M	27.97M	2.48M	1.94M	1.43M	1.06M
Net Debt	-15.14M	19.86M	18.42M	8.74M	24.16M	24.74M	-19.23M	-25.19M	-21.18M	-15.95M
Debt / Equity	0.01x	0.33x	0.73x	0.40x	0.64x	0.70x	0.06x	0.04x	0.03x	0.03x
Debt / EBITDA	0.14x	1.70x	4.02x	2.47x	4.20x	9.96x	-	4.50x	0.50x	-
Net Debt / EBITDA	-2.90x	1.53x	3.65x	2.10x	3.92x	8.81x	-	-58.58x	-7.43x	-
Interest Coverage	9.37x	2.18x	-8.25x	-6.05x	-2.56x	-5.58x	-12.81x	-5.51x	-	-
Total Equity+	54.16M	66.48M	27.8M	25.8M	40.7M	39.93M	39.32M	45.79M	48.55M	40.43M
Equity Growth %	0.66%	0.23%	-0.58%	-0.07%	0.58%	-0.02%	-0.02%	0.16%	0.06%	-0.17%
Book Value per Share	27.50	33.13	13.90	12.80	19.94	10.91	7.73	11.09	11.76	12.85
Total Shareholders' Equity	54.16M	66.48M	27.8M	25.8M	40.7M	39.93M	39.32M	45.79M	48.55M	40.43M
Common Stock	2K	2K	2K	0	0	0	4K	4K	4K	4K
Retained Earnings	-93.74M	-79.44M	-114.63M	-113.88M	-118.53M	-124.99M	-434.52M	-427.39M	-425.25M	-430.02M
Treasury Stock	-5.73M	-5.73M	-5.73M	-5.73M	-5.73M	-5.73M	-15.33M	-16.75M	-17.95M	-21.05M
Accumulated OCI	-240K	-52K	-5K	-22K	0	0	-85K	-1.64M	-1.29M	-2.72M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	3.72M	10.83M	6.07M	5.06M	400K	-4.95M	-6.45M	-3.86M	2.7M	-5.18M
Operating CF Margin %	0.06%	0.09%	0.05%	0.05%	0.01%	-0.06%	-0.06%	-0.03%	0.02%	-0.1%
Operating CF Growth %	-0.13%	1.91%	-0.44%	-0.17%	-0.92%	-13.38%	-0.3%	0.4%	1.7%	-2.92%
Net Income	21.64M	14.3M	-35.73M	-5.42M	-4.98M	-6.46M	-8.14M	-5.25M	25.13M	-10.44M
Depreciation & Amortization	2.44M	9.89M	11.06M	8.72M	8.07M	9.42M	3.48M	3.54M	2.66M	3.6M
Stock-Based Compensation	616K	1.02M	852K	634K	540K	524K	527K	438K	340K	240K
Deferred Taxes	-18.6M	-12.48M	27.53M	-133K	-363K	43K	22K	103K	-613K	16K
Other Non-Cash Items	448K	1.61M	3.77M	612K	540K	37K	1.79M	3.17M	-27.68M	3.16M
Working Capital Changes	-2.83M	-3.51M	-1.42M	655K	-3.42M	-8.52M	-4.13M	-5.85M	2.86M	-1.76M
Change in Receivables	-1.25M	-1.14M	-1.57M	3.03M	-3.33M	1.23M	-3.7M	-2.66M	3.74M	-1.13M
Change in Inventory	-811K	-1.35M	409K	-12K	-30K	-2.57M	1.26M	-2.1M	1.01M	859K
Change in Payables	-203K	439K	-1.24M	25K	-463K	-2.46M	-1M	-844K	1.12M	1.03M
Cash from Investing+	2.2M	-29.11M	-1.47M	8.69M	-5.82M	-1.33M	17.8M	-5.09M	16.18M	-12.04M
Capital Expenditures	-1.42M	-6.18M	-2.53M	-2.16M	-6.69M	-1.49M	-788K	-1.19M	-698K	-2.86M
CapEx % of Revenue	0.02%	0.05%	0.02%	0.02%	0.09%	0.02%	0.01%	0.01%	0%	0.05%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	18K	266K	0	2.1M	1.59M	0	19.18M	405K	20.91M	9.74M
Cash from Financing+	-4.1M	4.61M	-8.06M	-14.16M	5.67M	8.06M	-9.97M	8.94M	-3.07M	3.91M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-3.83M	-3.91M	-4.2M	-3.32M	0	0	-4.42M	-1.92M	-1.92M	-2.04M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-300K	-3.77M	-493K	-50K	-659K	-327K	-55K	-455K	-16K	-22K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	2.3M	4.65M	3.65M	2.9M	-6.29M	-6.45M	-7.24M	-5.05M	2M	-8.04M
FCF Margin %	0.04%	0.04%	0.03%	0.03%	-0.09%	-0.08%	-0.07%	-0.04%	0.01%	-0.15%
FCF Growth %	-0.24%	1.02%	-0.21%	-0.21%	-3.17%	-0.02%	-0.12%	0.3%	1.4%	-5.02%
FCF per Share	1.17	2.32	1.83	1.44	-3.08	-1.76	-1.42	-1.22	0.48	-2.56
FCF Conversion (FCF/Net Income)	0.17x	0.76x	-0.17x	6.88x	-0.09x	0.77x	2.16x	0.73x	1.23x	0.50x
Interest Paid	0	936K	856K	702K	1.08M	965K	717K	689K	261K	614K
Taxes Paid	62K	286K	127K	52K	102K	30K	344K	432K	651K	236K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	49.86%	23.71%	-75.8%	2.75%	-13.92%	-16.02%	-7.53%	-12.34%	4.66%	-23.46%
Return on Invested Capital (ROIC)	7.18%	3.69%	-6.81%	-8.44%	-2.88%	-8.35%	-20.52%	-11.45%	4.32%	-24.34%
Gross Margin	29.44%	28.51%	24%	17.54%	23.53%	17.89%	14.3%	23.08%	49.75%	20.72%
Net Margin	35.58%	11.4%	-30.19%	0.71%	-6.34%	-8.26%	-2.8%	-4.68%	1.36%	-19.56%
Debt / Equity	0.01x	0.33x	0.73x	0.40x	0.64x	0.70x	0.06x	0.04x	0.03x	0.03x
Interest Coverage	9.37x	2.18x	-8.25x	-6.05x	-2.56x	-5.58x	-12.81x	-5.51x	-	-
FCF Conversion	0.17x	0.76x	-0.17x	6.88x	-0.09x	0.77x	2.16x	0.73x	1.23x	0.50x
Revenue Growth	9.38%	106.27%	-5.68%	-11.96%	-29.99%	7.17%	36.33%	5.25%	43.86%	-66.93%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Investment	-	-	-	-	-	-	-	-	221K
Investment Growth	-	-	-	-	-	-	-	-	-
Building And Construction	-	-	-	-	-	-	-	45.78M	-
Building And Construction Growth	-	-	-	-	-	-	-	-	-
Real Estate And Investments	-	-	-	-	-	-	-	564K	-
Real Estate And Investments Growth	-	-	-	-	-	-	-	-	-
Product	-	-	11.98M	11.26M	28.88M	48M	57.15M	-	-
Product Growth	-	-	-	-6.06%	156.54%	66.22%	19.05%	-	-
Mobile Imaging	-	-	-	-	38.69M	43.54M	40.55M	-	-
Mobile Imaging Growth	-	-	-	-	-	12.53%	-6.86%	-	-
Camera Support	-	-	-	-	6.51M	6.83M	7.13M	-	-
Camera Support Growth	-	-	-	-	-	4.87%	4.33%	-	-
Camera	-	-	-	-	3.45M	7.96M	6.97M	-	-
Camera Growth	-	-	-	-	-	130.70%	-12.36%	-	-
Real Estate	-	-	-	82K	52K	-	-	-	-
Real Estate Growth	-	-	-	-	-36.59%	-	-	-	-
Service	-	-	92.2M	102.85M	-	-	-	-	-
Service Growth	-	-	-	11.55%	-	-	-	-	-
DIS	48.3M	49.02M	-	-	-	-	-	-	-
DIS Growth	-	1.47%	-	-	-	-	-	-	-
Mobile Healthcare	47.21M	42.85M	-	-	-	-	-	-	-
Mobile Healthcare Growth	-	-9.23%	-	-	-	-	-	-	-
Medical Device Sales and Service	16.09M	14.39M	-	-	-	-	-	-	-
Medical Device Sales and Service Growth	-	-10.52%	-	-	-	-	-	-	-
621512 Diagnostic Imaging Centers	13.87M	12.08M	-	-	-	-	-	-	-
621512 Diagnostic Imaging Centers Growth	-	-12.90%	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Non-US	-	1M	1.2M	300K	300K	200K	200K	-	-
Non-US Growth	-	-	20.00%	-75.00%	0.00%	-33.33%	0.00%	-	-

Frequently Asked Questions

Growth & Financials

Star Equity Holdings, Inc. (STRR) reported $113.5M in revenue for fiscal year 2024. This represents a 111% increase from $53.7M in 2011.

Star Equity Holdings, Inc. (STRR) saw revenue decline by 66.9% over the past year.

Star Equity Holdings, Inc. (STRR) reported a net loss of $6.1M for fiscal year 2024.

Dividend & Returns

Yes, Star Equity Holdings, Inc. (STRR) pays a dividend with a yield of 5.92%. This makes it attractive for income-focused investors.

Star Equity Holdings, Inc. (STRR) has a return on equity (ROE) of -23.5%. Negative ROE indicates the company is unprofitable.

Star Equity Holdings, Inc. (STRR) had negative free cash flow of $9.5M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Star Equity Holdings, Inc. (STRR) 10-Year Financial Performance & Capital Metrics

STRR • • Industrial / General

HealthcareDiagnostics & ResearchClinical Laboratory ServicesSpecialized Testing Laboratories

Revenue $53M -66.9%
EBITDA -$5M -268.9%
Net Income -$10M -574.9%
EPS (Diluted) -3.97 -257.7%
Gross Margin 20.72% -58.4%
EBITDA Margin -9.02% -610.6%
Operating Margin -15.77% -1939.8%
Net Margin -19.56% -1535.8%
ROE -23.46% -603.5%
ROIC -24.34% -663.0%
Debt/Equity 0.03 -10.8%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Healthy dividend yield of 5.9%
✓Share count reduced 23.8% through buybacks
✓Trading at only 0.9x book value
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Sales declining 6.1% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.41%

5Y-6.06%

3Y-20.59%

TTM56.35%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-109.32%

EPS CAGR

10Y-

5Y-

3Y-

TTM48.46%

ROCE

10Y Avg-7.79%

5Y Avg-12.91%

3Y Avg-7.55%

Latest-18.47%

Peer Comparison

Specialized Testing Laboratories

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
RDNTRadNet, Inc.	5.64B	72.99	1951.60	13.18%	-0.65%	-0.97%	0.8%	1.53
IDXXIDEXX Laboratories, Inc.	56.86B	712.12	66.74	6.46%	24.65%	65.81%	1.4%	0.62
CDNACareDx, Inc	1.06B	20.57	22.12	19.07%	16.97%	19.53%	2.98%	0.07
TRIBTrinity Biotech plc	13.23M	0.71	-0.40	8.31%	-73.78%
NEOGNeogen Corporation	2.06B	9.46	-1.88	-3.2%	-68.47%	-28.64%		0.44
STRRStar Equity Holdings, Inc.	38.07M	10.96	-2.76	-66.93%	-5.36%	-8.98%		0.03
BGLCBioNexus Gene Lab Corp.	8.72M	3.69	-4.10	-2.66%	-24.27%	-33.7%		0.03
NEONeoGenomics, Inc.	1.66B	12.83	-4.14	11.65%	-16%	-13.54%		0.67

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	60.83M	125.47M	118.34M	104.18M	72.93M	78.16M	106.56M	112.15M	161.34M	53.36M
Revenue Growth %	0.09%	1.06%	-0.06%	-0.12%	-0.3%	0.07%	0.36%	0.05%	0.44%	-0.67%
Cost of Goods Sold+	42.92M	89.69M	89.94M	85.91M	55.77M	64.18M	91.32M	86.27M	81.07M	42.3M
COGS % of Revenue	0.71%	0.71%	0.76%	0.82%	0.76%	0.82%	0.86%	0.77%	0.5%	0.79%
Gross Profit+	17.91M	35.77M	28.4M	18.27M	17.16M	13.99M	15.24M	25.88M	80.27M	11.05M
Gross Margin %	0.29%	0.29%	0.24%	0.18%	0.24%	0.18%	0.14%	0.23%	0.5%	0.21%
Gross Profit Growth %	0.08%	1%	-0.21%	-0.36%	-0.06%	-0.18%	0.09%	0.7%	2.1%	-0.86%
Operating Expenses+	15.13M	32.69M	26.5M	22.82M	19.07M	21.2M	26.84M	28.98M	78.88M	19.47M
OpEx % of Revenue	0.25%	0.26%	0.22%	0.22%	0.26%	0.27%	0.25%	0.26%	0.49%	0.36%
Selling, General & Admin	14.63M	30.04M	24.84M	20.46M	15.9M	18.64M	22.59M	27.26M	77.42M	16.99M
SG&A % of Revenue	0.24%	0.24%	0.21%	0.2%	0.22%	0.24%	0.21%	0.24%	0.48%	0.32%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	506K	4.51M	3M	2.36M	3.17M	2.56M	4.24M	1.72M	1.47M	2.48M
Operating Income+	2.77M	3.08M	-6.02M	-4.54M	-1.91M	-7.21M	-11.6M	-3.1M	1.38M	-8.41M
Operating Margin %	0.05%	0.02%	-0.05%	-0.04%	-0.03%	-0.09%	-0.11%	-0.03%	0.01%	-0.16%
Operating Income Growth %	0.1%	0.11%	-2.95%	0.24%	0.58%	-2.78%	-0.61%	0.73%	1.45%	-7.08%
EBITDA+	5.21M	12.97M	5.04M	4.16M	6.17M	2.81M	-6.66M	430K	2.85M	-4.81M
EBITDA Margin %	0.09%	0.1%	0.04%	0.04%	0.08%	0.04%	-0.06%	0%	0.02%	-0.09%
EBITDA Growth %	0.17%	1.49%	-0.61%	-0.17%	0.48%	-0.54%	-3.37%	1.06%	5.63%	-2.69%
D&A (Non-Cash Add-back)	2.44M	9.89M	11.06M	8.71M	8.07M	10.02M	4.93M	3.54M	1.47M	3.6M
EBIT	2.54M	5.28M	-6.32M	-4.65M	-2.19M	-3.86M	-7.97M	-3.54M	1.38M	-8.41M
Net Interest Income+	-24K	-1.41M	-730K	-751K	-746K	-1.29M	-905K	-564K	372K	633K
Interest Income	272K	0	0	0	0	0	0	0	372K	633K
Interest Expense	296K	1.41M	730K	751K	746K	1.29M	905K	564K	0	0
Other Income/Expense	-257K	-1.2M	-1.03M	-855K	-1.03M	2.05M	2.72M	-2.34M	1.19M	-1.76M
Pretax Income+	2.52M	1.89M	-7.05M	-5.4M	-2.94M	-5.16M	-8.87M	-5.44M	2.57M	-10.18M
Pretax Margin %	0.04%	0.02%	-0.06%	-0.05%	-0.04%	-0.07%	-0.08%	-0.05%	0.02%	-0.19%
Income Tax+	-19.12M	-12.42M	27.99M	-1.56M	-199K	129K	60K	383K	370K	263K
Effective Tax Rate %	8.6%	7.59%	5.07%	-0.14%	1.57%	1.25%	0.34%	0.96%	0.86%	1.03%
Net Income+	21.64M	14.3M	-35.73M	736K	-4.63M	-6.46M	-2.98M	-5.25M	2.2M	-10.44M
Net Margin %	0.36%	0.11%	-0.3%	0.01%	-0.06%	-0.08%	-0.03%	-0.05%	0.01%	-0.2%
Net Income Growth %	7.74%	-0.34%	-3.5%	1.02%	-7.29%	-0.4%	0.54%	-0.76%	1.42%	-5.75%
Net Income (Continuing)	21.64M	14.3M	-35.04M	-3.84M	-2.74M	-5.29M	-8.93M	-5.83M	2.2M	-10.44M
Discontinued Operations	0	0	0	4.58M	-1.89M	-1.17M	5.95M	575K	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	55.00	35.50	-17.87	2.00	-2.56	-2.29	-0.96	-1.27	-1.11	-3.97
EPS Growth %	7.46%	-0.35%	-1.5%	1.11%	-2.28%	0.11%	0.58%	-0.32%	0.13%	-2.58%
EPS (Basic)	56.50	36.50	-17.87	0.04	-2.56	-2.29	-0.96	-1.27	-1.11	-3.97
Diluted Shares Outstanding	1.97M	2.01M	2M	2.02M	2.04M	3.66M	5.08M	4.13M	4.13M	3.15M
Basic Shares Outstanding	1.92M	1.96M	2M	2.02M	2.04M	3.66M	5.08M	4.13M	4.13M	3.15M
Dividend Payout Ratio	0.18%	0.27%	-	4.51%	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	31.75M	27.08M	25.58M	21.19M	29.55M	48.94M	49.16M	55.51M	45.85M	40.14M
Cash & Short-Term Investments	19.09M	3.12M	1.97M	1.7M	1.77M	3.23M	21.71M	27.12M	22.61M	17.01M
Cash Only	15.87M	2.2M	1.88M	1.54M	1.75M	3.23M	21.71M	27.12M	22.61M	17.01M
Short-Term Investments	3.23M	917K	97K	153K	26K	0	0	0	0	0
Accounts Receivable	7.27M	14.5M	15.89M	12.64M	12.92M	12.97M	25.75M	26.27M	19.71M	20.09M
Days Sales Outstanding	43.65	42.19	49	44.29	64.64	60.59	88.2	85.5	44.59	137.45
Inventory	4.38M	5.99M	5.5M	5.4M	7.03M	9.79M	0	0	0	0
Days Inventory Outstanding	37.26	24.36	22.33	22.95	46	55.66	-	-	-	-
Other Current Assets	997K	3.47M	2.21M	1.45M	7.83M	22.95M	222K	2.12M	3.53M	3.04M
Total Non-Current Assets+	32.37M	79.18M	41.13M	29.4M	61.01M	40.52M	12.08M	12.43M	15.11M	12.44M
Property, Plant & Equipment	6.25M	31.41M	28.36M	21.64M	12.52M	12.7M	848K	1.36M	1.85M	1.27M
Fixed Asset Turnover	9.73x	3.99x	4.17x	4.81x	5.82x	6.16x	125.66x	82.59x	87.12x	42.15x
Goodwill	2.9M	6.24M	2.39M	1.75M	9.98M	9.54M	4.22M	4.88M	5.75M	5.7M
Intangible Assets	3.08M	11.63M	7.83M	5.23M	19.02M	16.9M	5.49M	4.52M	3.63M	2.49M
Long-Term Investments	0	0	0	275K	0	0	0	0	0	0
Other Non-Current Assets	1.56M	2.89M	2.54M	507K	19.49M	1.38M	182K	206K	522K	335K
Total Assets+	64.11M	106.26M	66.7M	50.59M	90.56M	89.46M	61.24M	67.94M	60.96M	52.58M
Asset Turnover	0.95x	1.18x	1.77x	2.06x	0.81x	0.87x	1.74x	1.65x	2.65x	1.01x
Asset Growth %	0.53%	0.66%	-0.37%	-0.24%	0.79%	-0.01%	-0.32%	0.11%	-0.1%	-0.14%
Total Current Liabilities+	8.71M	22.67M	16.97M	13.22M	44.48M	42.99M	19.69M	21.12M	11.21M	11.22M
Accounts Payable	1.37M	6.51M	5.21M	5.21M	6.46M	4.95M	871K	1.68M	868K	1.79M
Days Payables Outstanding	11.64	26.51	21.13	22.12	42.29	28.16	3.48	7.1	3.91	15.44
Short-Term Debt	0	5.36M	0	0	22.25M	20.67M	750K	1.25M	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	533K	170K	96K	129K
Other Current Liabilities	2.45M	3.96M	6.34M	3.86M	8.23M	10.7M	0	75K	0	0
Current Ratio	3.65x	1.19x	1.51x	1.60x	0.66x	1.14x	2.50x	2.63x	4.09x	3.58x
Quick Ratio	3.14x	0.93x	1.18x	1.19x	0.51x	0.91x	2.50x	2.63x	4.09x	3.58x
Cash Conversion Cycle	69.27	40.05	50.19	45.12	68.35	88.09	-	-	-	-
Total Non-Current Liabilities+	1.25M	17.11M	21.93M	11.58M	5.39M	6.54M	2.23M	1.03M	1.19M	933K
Long-Term Debt	0	16.07M	19.5M	9.5M	740K	3.7M	1.25M	0	0	0
Capital Lease Obligations	0	0	0	0	1.21M	1.73M	118K	348K	664K	441K
Deferred Tax Liabilities	0	0	254K	121K	11K	51K	0	0	0	0
Other Non-Current Liabilities	1.25M	1.04M	2.18M	1.96M	3.43M	1.06M	865K	680K	530K	492K
Total Liabilities	9.96M	39.78M	38.9M	24.79M	49.86M	49.53M	21.93M	22.15M	12.4M	12.15M
Total Debt+	724K	22.07M	20.3M	10.29M	25.9M	27.97M	2.48M	1.94M	1.43M	1.06M
Net Debt	-15.14M	19.86M	18.42M	8.74M	24.16M	24.74M	-19.23M	-25.19M	-21.18M	-15.95M
Debt / Equity	0.01x	0.33x	0.73x	0.40x	0.64x	0.70x	0.06x	0.04x	0.03x	0.03x
Debt / EBITDA	0.14x	1.70x	4.02x	2.47x	4.20x	9.96x	-	4.50x	0.50x	-
Net Debt / EBITDA	-2.90x	1.53x	3.65x	2.10x	3.92x	8.81x	-	-58.58x	-7.43x	-
Interest Coverage	9.37x	2.18x	-8.25x	-6.05x	-2.56x	-5.58x	-12.81x	-5.51x	-	-
Total Equity+	54.16M	66.48M	27.8M	25.8M	40.7M	39.93M	39.32M	45.79M	48.55M	40.43M
Equity Growth %	0.66%	0.23%	-0.58%	-0.07%	0.58%	-0.02%	-0.02%	0.16%	0.06%	-0.17%
Book Value per Share	27.50	33.13	13.90	12.80	19.94	10.91	7.73	11.09	11.76	12.85
Total Shareholders' Equity	54.16M	66.48M	27.8M	25.8M	40.7M	39.93M	39.32M	45.79M	48.55M	40.43M
Common Stock	2K	2K	2K	0	0	0	4K	4K	4K	4K
Retained Earnings	-93.74M	-79.44M	-114.63M	-113.88M	-118.53M	-124.99M	-434.52M	-427.39M	-425.25M	-430.02M
Treasury Stock	-5.73M	-5.73M	-5.73M	-5.73M	-5.73M	-5.73M	-15.33M	-16.75M	-17.95M	-21.05M
Accumulated OCI	-240K	-52K	-5K	-22K	0	0	-85K	-1.64M	-1.29M	-2.72M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	3.72M	10.83M	6.07M	5.06M	400K	-4.95M	-6.45M	-3.86M	2.7M	-5.18M
Operating CF Margin %	0.06%	0.09%	0.05%	0.05%	0.01%	-0.06%	-0.06%	-0.03%	0.02%	-0.1%
Operating CF Growth %	-0.13%	1.91%	-0.44%	-0.17%	-0.92%	-13.38%	-0.3%	0.4%	1.7%	-2.92%
Net Income	21.64M	14.3M	-35.73M	-5.42M	-4.98M	-6.46M	-8.14M	-5.25M	25.13M	-10.44M
Depreciation & Amortization	2.44M	9.89M	11.06M	8.72M	8.07M	9.42M	3.48M	3.54M	2.66M	3.6M
Stock-Based Compensation	616K	1.02M	852K	634K	540K	524K	527K	438K	340K	240K
Deferred Taxes	-18.6M	-12.48M	27.53M	-133K	-363K	43K	22K	103K	-613K	16K
Other Non-Cash Items	448K	1.61M	3.77M	612K	540K	37K	1.79M	3.17M	-27.68M	3.16M
Working Capital Changes	-2.83M	-3.51M	-1.42M	655K	-3.42M	-8.52M	-4.13M	-5.85M	2.86M	-1.76M
Change in Receivables	-1.25M	-1.14M	-1.57M	3.03M	-3.33M	1.23M	-3.7M	-2.66M	3.74M	-1.13M
Change in Inventory	-811K	-1.35M	409K	-12K	-30K	-2.57M	1.26M	-2.1M	1.01M	859K
Change in Payables	-203K	439K	-1.24M	25K	-463K	-2.46M	-1M	-844K	1.12M	1.03M
Cash from Investing+	2.2M	-29.11M	-1.47M	8.69M	-5.82M	-1.33M	17.8M	-5.09M	16.18M	-12.04M
Capital Expenditures	-1.42M	-6.18M	-2.53M	-2.16M	-6.69M	-1.49M	-788K	-1.19M	-698K	-2.86M
CapEx % of Revenue	0.02%	0.05%	0.02%	0.02%	0.09%	0.02%	0.01%	0.01%	0%	0.05%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	18K	266K	0	2.1M	1.59M	0	19.18M	405K	20.91M	9.74M
Cash from Financing+	-4.1M	4.61M	-8.06M	-14.16M	5.67M	8.06M	-9.97M	8.94M	-3.07M	3.91M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-3.83M	-3.91M	-4.2M	-3.32M	0	0	-4.42M	-1.92M	-1.92M	-2.04M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-300K	-3.77M	-493K	-50K	-659K	-327K	-55K	-455K	-16K	-22K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	2.3M	4.65M	3.65M	2.9M	-6.29M	-6.45M	-7.24M	-5.05M	2M	-8.04M
FCF Margin %	0.04%	0.04%	0.03%	0.03%	-0.09%	-0.08%	-0.07%	-0.04%	0.01%	-0.15%
FCF Growth %	-0.24%	1.02%	-0.21%	-0.21%	-3.17%	-0.02%	-0.12%	0.3%	1.4%	-5.02%
FCF per Share	1.17	2.32	1.83	1.44	-3.08	-1.76	-1.42	-1.22	0.48	-2.56
FCF Conversion (FCF/Net Income)	0.17x	0.76x	-0.17x	6.88x	-0.09x	0.77x	2.16x	0.73x	1.23x	0.50x
Interest Paid	0	936K	856K	702K	1.08M	965K	717K	689K	261K	614K
Taxes Paid	62K	286K	127K	52K	102K	30K	344K	432K	651K	236K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	49.86%	23.71%	-75.8%	2.75%	-13.92%	-16.02%	-7.53%	-12.34%	4.66%	-23.46%
Return on Invested Capital (ROIC)	7.18%	3.69%	-6.81%	-8.44%	-2.88%	-8.35%	-20.52%	-11.45%	4.32%	-24.34%
Gross Margin	29.44%	28.51%	24%	17.54%	23.53%	17.89%	14.3%	23.08%	49.75%	20.72%
Net Margin	35.58%	11.4%	-30.19%	0.71%	-6.34%	-8.26%	-2.8%	-4.68%	1.36%	-19.56%
Debt / Equity	0.01x	0.33x	0.73x	0.40x	0.64x	0.70x	0.06x	0.04x	0.03x	0.03x
Interest Coverage	9.37x	2.18x	-8.25x	-6.05x	-2.56x	-5.58x	-12.81x	-5.51x	-	-
FCF Conversion	0.17x	0.76x	-0.17x	6.88x	-0.09x	0.77x	2.16x	0.73x	1.23x	0.50x
Revenue Growth	9.38%	106.27%	-5.68%	-11.96%	-29.99%	7.17%	36.33%	5.25%	43.86%	-66.93%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Investment	-	-	-	-	-	-	-	-	221K
Investment Growth	-	-	-	-	-	-	-	-	-
Building And Construction	-	-	-	-	-	-	-	45.78M	-
Building And Construction Growth	-	-	-	-	-	-	-	-	-
Real Estate And Investments	-	-	-	-	-	-	-	564K	-
Real Estate And Investments Growth	-	-	-	-	-	-	-	-	-
Product	-	-	11.98M	11.26M	28.88M	48M	57.15M	-	-
Product Growth	-	-	-	-6.06%	156.54%	66.22%	19.05%	-	-
Mobile Imaging	-	-	-	-	38.69M	43.54M	40.55M	-	-
Mobile Imaging Growth	-	-	-	-	-	12.53%	-6.86%	-	-
Camera Support	-	-	-	-	6.51M	6.83M	7.13M	-	-
Camera Support Growth	-	-	-	-	-	4.87%	4.33%	-	-
Camera	-	-	-	-	3.45M	7.96M	6.97M	-	-
Camera Growth	-	-	-	-	-	130.70%	-12.36%	-	-
Real Estate	-	-	-	82K	52K	-	-	-	-
Real Estate Growth	-	-	-	-	-36.59%	-	-	-	-
Service	-	-	92.2M	102.85M	-	-	-	-	-
Service Growth	-	-	-	11.55%	-	-	-	-	-
DIS	48.3M	49.02M	-	-	-	-	-	-	-
DIS Growth	-	1.47%	-	-	-	-	-	-	-
Mobile Healthcare	47.21M	42.85M	-	-	-	-	-	-	-
Mobile Healthcare Growth	-	-9.23%	-	-	-	-	-	-	-
Medical Device Sales and Service	16.09M	14.39M	-	-	-	-	-	-	-
Medical Device Sales and Service Growth	-	-10.52%	-	-	-	-	-	-	-
621512 Diagnostic Imaging Centers	13.87M	12.08M	-	-	-	-	-	-	-
621512 Diagnostic Imaging Centers Growth	-	-12.90%	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Non-US	-	1M	1.2M	300K	300K	200K	200K	-	-
Non-US Growth	-	-	20.00%	-75.00%	0.00%	-33.33%	0.00%	-	-

Frequently Asked Questions

Growth & Financials

Star Equity Holdings, Inc. (STRR) reported $113.5M in revenue for fiscal year 2024. This represents a 111% increase from $53.7M in 2011.

Star Equity Holdings, Inc. (STRR) saw revenue decline by 66.9% over the past year.

Star Equity Holdings, Inc. (STRR) reported a net loss of $6.1M for fiscal year 2024.

Dividend & Returns

Yes, Star Equity Holdings, Inc. (STRR) pays a dividend with a yield of 5.92%. This makes it attractive for income-focused investors.

Star Equity Holdings, Inc. (STRR) has a return on equity (ROE) of -23.5%. Negative ROE indicates the company is unprofitable.

Star Equity Holdings, Inc. (STRR) had negative free cash flow of $9.5M in fiscal year 2024, likely due to heavy capital investments.